Skip to content

The significance of intestinal edema in sepsis

The significance of intestinal edema in sepsis - SIES

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00010196
Enrollment
170
Registered
2016-04-01
Start date
2016-04-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis, severe sepsis, septic shock, blood poisoning R65.0 R65.1 R57.2

Interventions

Group 1: septic patients, surgical (Standard care with no study related interventions) Group 2: septic patients, non surgical (Standard care with no study related interventions) Group 3: surgical pati

Sponsors

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Anästhesiologie und Operative Intensivmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Arm 1: septic patients, surgical. Detailed: patients treated in the intensive care unit for severe sepsis and main surgery; severe sepsis or septic shock since = 36h; main surgery since = 48h. Arm 2: septic patients, non surgical. Detailed: patients treated in the intensive care unit for severe sepsis; severe sepsis or septic shock since = 36h. Arm 3: surgical patients. Non septic. Detailed: patients treated in the intensive care unit after planned main surgery since = 36h; perioperative need for = 3000ml of fluids. Arm 4: healthy subjects undergoing routine endoscopy. Detailed: ambulant patients; planned examination of the upper and lower intestinal tract by endoscopy.

Exclusion criteria

Exclusion criteria: inflammatory bowel disease (active), chronic liver failure (Child-Pugh-Classification C) or HIV disease, identified portal hypertension, identified portal vein thrombosis, identified hepatosplenomegaly, immunosupression, bone marrow or hematopoietic stem cell transplantation within the last 12 month, pregnancy or lactation, enrollment in an interventional study (within the last 30 days), enrollment in this study before, best supportive care.

Design outcomes

Primary

MeasureTime frame
Total wall thickness (TWT). Day 0, day 3 and day 5 after patient enrollment. Endoscopic ultrasound (EUS).

Secondary

MeasureTime frame
a) Severity of the disease. Day 0 to 5 (daily) after patient enrollment. SOFA-Score. b) Incidence of surgery. Day 0 to 5 (daily) after patient enrollment. +/-. c) Incidence of death. Day 0 to 5 (daily) after patient enrollment; At the day of ICU discharge; At day 30after patient enrollment. +/-. d) Intestinal motility. Day 0 to 5 (daily) after patient enrollment. Residual gastric volume; intensity of bowel sounds; time delay to first faecal evacuation. e) Fluid balance. Day 0 to 5 (daily) after patient enrollment. Calculation of balance from intake/output. f) Colloidosmotic pressure. Day 0 to 5 (daily) after patient enrollment. Oncometry. g) Impairment of mucosal perfusion. Day 0 to 5 (daily) after patient enrollment. Time-to-peak and AUC analysis.

Countries

Germany

Contacts

Public ContactIngmar Lautenschläger

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Anästhesiologie und Operative Intensivmedizin

ingmar.lautenschlaeger@uksh.de0431 597 2991

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026